Blocking the S1P/S1PR1-mediated inflammatory response by FTY720 administration has been shown to exhibit positive effects against heart disease [57], and, as observed in ischaemia and hypoxic injury mouse models, it has been proven to be protective against acute and chronic myocardial injury [263,273]. This evidence concerns the gene S1PR1 and heart disorder.